Class II · Moderate risk
Ephedrine 25 Guaifenesin 200 Tablet
CGMP Deviations
FDA Drug Recalls
1,206 recalls · Class II, newest first
Class II · Moderate risk
Nutralox Peppermint Antacid
CGMP Deviations
Class II · Moderate risk
Spearmint Antacid Tablet
CGMP Deviations
Class II · Moderate risk
Trial Antacid Tablet
CGMP Deviations
Class II · Moderate risk
Cherry Antacid Tablet
CGMP Deviations
Class II · Moderate risk
Peppermint Antacid tablet
CGMP Deviations
Class II · Moderate risk
HPC Tablet
CGMP Deviations
Class II · Moderate risk
APAP 500 mg SRC Coated
CGMP Deviations
Class II · Moderate risk
APAP 500 mg tablet
CGMP Deviations
Class II · Moderate risk
Extra-Strength Unaspirin caplet
CGMP Deviations
Class II · Moderate risk
Coated APAP 500 mg caplet
CGMP Deviations
Class II · Moderate risk
Normed APAP 325 mg
CGMP Deviations
Class II · Moderate risk
Coated APAP 325mg
CGMP Deviations
Class II · Moderate risk
APAP 325 mg
CGMP Deviations
Class II · Moderate risk
APAP 500 mg Phenyl HCl 5mg tablet
CGMP Deviations
Class II · Moderate risk
APAP 325 mg/Phenylephrine HCl
CGMP Deviations
Class II · Moderate risk
Coated APAP 325 mg Phenyl HCl 5 mg tablet
CGMP Deviations
Class II · Moderate risk
Dologen 325 Caplet
CGMP Deviations
Class II · Moderate risk
Kramer Novis Tusicof Caplet
CGMP Deviations
Class II · Moderate risk
Zee Cold Tabs
CGMP Deviations
Class II · Moderate risk
4-Component Cold Tabs
CGMP Deviations
Class II · Moderate risk
3-Component Cold Tabs
CGMP Deviations
Class II · Moderate risk
Inhub Wixela
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk
Warfarin Sodium Tablets
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk
Warfarin Sodium Tablets
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.